[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [Vera Therapeutics, Inc. Class A Common Stock](/topic/$vera) ### Sentiment: XX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$vera/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XX% -XX% **1 Month**: XX% +10% **6 Months**: XX% -XX% **1 Year**: XX% -XX% **1-Year High**: XXX% on 2025-02-07 **1-Year Low**: XX% on 2025-04-19 **Most Supportive Themes** - **Positive Clinical Trial Results:** (40%) Vera Therapeutics' atacicept drug showed positive results in a kidney disease trial. - **M&A Potential:** (30%) Goldman Sachs identifies Vera Therapeutics as a potential M&A candidate. **Most Critical Themes** - **Government Shutdown Impact:** (30%) The US government shutdown is impacting FDA drug approval applications, potentially delaying Vera Therapeutics. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | X | X% | XX | XX% | XXX | XX% | | Reddit | X | X% | X | X% | X | X% | | | | | | | | | | Total | X | X% | XX | XX% | XXX | XX% |
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Vera Therapeutics, Inc. Class A Common Stock
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -XX%
1 Month: XX% +10%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2025-02-07
1-Year Low: XX% on 2025-04-19
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | X | X% | XX | XX% | XXX | XX% |
X | X% | X | X% | X | X% | |
Total | X | X% | XX | XX% | XXX | XX% |
/topic/$vera/sentiment